Florida providers going to trial in $360 million antitrust case against HealthFirst

Several healthcare providers and physicians in Florida are planning on going to trial with integrated system HealthFirst, seeking more than $360 million in damages for alleged antitrust violations.

OmniHealthcare and Interventional Spine Institute of Florida, among others, have accused HealthFirst of “intimidating physicians or otherwise obstructing their ability to practice medicine in southern Brevard County” by supposedly refusing to renew contracts unless the doctors refer patients exclusively to HealthFirst providers. The intimidation, according to the complaint, began after HealthFirst acquired the physician group Melbourne Internal Medicine Associates in 2013.

A federal judge denied five motions from HealthFirst seeking to dismiss some of the charges in the case’s final pretrial conference July 21, and set a trial date of Aug. 15.

One lawyer for the plaintiffs, Joe Whatley, told legal news website Law360 the judge’s lastest actions were close to a “total victory” for the physicians.

“Our clients are really concerned about the healthcare in Brevard County,” Whatley said. “They want to see it improved and they want to see competition in Brevard County.”

HealthFirst Vice President of Marketing and Communications Matthew Gerrell said in a statement that any settlement to avoid a trial is unlikely, arguing the physicians’ real motivation is to break up the integrated health system model the company has developed.

“There are those in the health services industry that do not believe this is the right model, and feel threatened, as they have richly profited from the historic 'fee for service' model of healthcare for decades,” Gerrell said. “Their reaction is to file lawsuits, and try to 'cash in,' while their business models erode due to the evolving economics of healthcare.”

HealthFirst has faced similar lawsuits over the past several years. Health News Florida reported the company was sued in February 2015 over allegedly giving kickbacks to physicians who referred patients only to its providers. In September 2015, it was sued on antitrust grounds over its purchase of Space Coast Cancer Center, which has three locations in Brevard County. 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.